Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
2.02
0.01 (0.50%)
At close: Jun 02, 2025, 1:53 PM
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
15
Market Cap
150.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|